Close

Nabriva Therapeutics AG (NBRV) PT Raised to $6 at BofA/Merrill Lynch

August 20, 2019 6:20 AM EDT Send to a Friend
BofA/Merrill Lynch analyst Jason Gerberry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login